Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-04-25 | 2024-03 | -4.55 | -4.4 | 0.15 | 3.30% |
2024-02-02 | 2023-12 | 1.52 | 1.7 | 0.18 | 11.84% |
2023-10-26 | 2023-09 | 1.76 | 2 | 0.24 | 13.64% |
2023-07-27 | 2023-06 | 1.99 | 1.75 | -0.24 | -12.06% |
2023-04-27 | 2023-03 | 1.98 | 2.05 | 0.07 | 3.54% |
2023-02-02 | 2022-12 | 1.71 | 1.82 | 0.11 | 6.43% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-10-10 | Morgan Stanley | Upgrade | Underweight | Underweight |
2023-10-08 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-10-05 | Truist Securities | Upgrade | Buy | Buy |
2023-09-14 | Cantor Fitzgerald | Upgrade | Overweight | Overweight |
2023-09-14 | TD Cowen | Upgrade | Market Perform | Market Perform |
2023-09-14 | Truist Securities | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-03-07 | BOERNER CHRISTOPHER S | Chief Executive Officer | 101.21K | Conversion of Exercise of derivative security |
2024-03-07 | CAFORIO GIOVANNI | Officer and Director | 432.27K | Conversion of Exercise of derivative security |
2024-03-07 | ELKINS DAVID VINCENT | Chief Financial Officer | 195.18K | Conversion of Exercise of derivative security |
2024-03-07 | GALLMAN CARI | Officer | 1.43K | Conversion of Exercise of derivative security |
2024-03-07 | HIRAWAT SAMIT | Officer | 60.28K | Conversion of Exercise of derivative security |
2024-03-07 | HOCH LYNELLE BAUMGARDNER | Officer | 1.73K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 203.74M | 13.03B | 9.75% |
2023-06-29 | Blackrock Inc. | 172.67M | 11.04B | 8.27% |
2023-06-29 | JP Morgan Chase & Company | 103.31M | 6.61B | 4.95% |
2023-06-29 | State Street Corporation | 92.57M | 5.92B | 4.43% |
2023-06-29 | Capital International Investors | 69.30M | 4.43B | 3.32% |
2023-06-29 | FMR, LLC | 46.75M | 2.99B | 2.24% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 65.55M | 4.19B | 3.14% |
2023-06-29 | Vanguard 500 Index Fund | 50.02M | 3.20B | 2.39% |
2023-05-30 | Fidelity 500 Index Fund | 23.79M | 1.53B | 1.14% |
2023-08-30 | SPDR S&P 500 ETF Trust | 23.15M | 1.43B | 1.11% |
2023-08-30 | iShares Core S&P 500 ETF | 19.65M | 1.21B | 0.94% |
2023-06-29 | Vanguard Index-Value Index Fund | 18.25M | 1.17B | 0.87% |
Dividend | Date |
---|---|
0.5 | 2024-05-06 |
0.6 | 2024-04-05 |
0.6 | 2024-04-04 |
0.6 | 2024-01-04 |
0.57 | 2023-10-05 |
0.57 | 2023-07-06 |
Split | Date |
---|---|
1000000 : 951777 | 2001-08-07 |
1.05067 : 1 | 2001-08-06 |
2 : 1 | 1999-03-01 |
2 : 1 | 1997-03-03 |
2 : 1 | 1987-06-10 |
2 : 1 | 1983-05-27 |
-
20 some years in pharma stocks have come to halt. Just let them all go. A sad ending but a necessary cut. Adios
-
So this is finally the turn around? Who says you can’t call the bottom? Scooped it up in the 48/49 level. Let it rip
-
I’m a buyer when it hits $35 as forecasted.
-
Everyone states buy,buy,buy while sell,sell,sell. What a bunch of crooks! SEC needs to investigate!
-
Everyone states buy,buy,buy while sell,sell,sell. What a bunch of crooks!!!
-
All thanks to Mrs. Karen J Adams that helped me achieve my dreams through her trading program, I made over $30,000 in duration of 4 days she's so excellent and amazing. Visit her on TELEGRAM ᏦᎪᎡᎬΝ Ꭻ ᎪᎠᎪᎷՏ or WhatsApp +❶❽❶❷❷❼⓿❻❽⓿❼
-
Calling all cars, Calling all cars️️
-
$BMY finally broke through 78!!
-
-
$BMY What in the world is going here??? These folks make a ton of money, pay a dividend, and they own 3 out of the top 5 drugs on the market. They get approvals left and right, and they grind out more and more money every year. Are people out of their minds??? This is a STRONG BUY
-
They pay a great dividend, they’ve had great trial runs on new drugs, and they make some of the best steadily sold drugs on the market. Just about every amazing analyst I follow owns $BMY. Sometimes the market gets is wrong for a bit. Get ready, she’s about to rocket.
-
-
-
Back to $50’s puts
-
$BMY...check out $ARCT.. your welcome
-
Anybody look at Buffets portfolio and unimpressed by all the growth he missed?
-
Does BMY have some type of news coming out that should impact the share price, I have had several people suggest I add this stock to my portfolio. But looking at the current share price it looks to be at the peak.
-
Bagholding plus ER!! $BMY double-win tomorrow! When is ER before of after market?
-
This is America $BMY defense stock
-
-
PGGM Investments Takes Position in Bristol-Myers Squibb (NYSE:BMY)
news.google.com • -
Barclays Cuts Bristol-Myers Squibb (NYSE:BMY) Price Target to $43.00
news.google.com • -
Trend Tracker for (BMY)
news.google.com • -
2 Very Cheap Turnarounds Yielding Up To 7%
seekingalpha.com • -
Bristol-Myers Squibb (NYSE:BMY) Shares Up 1.4% After Earnings Beat
news.google.com • -
Bristol-Myers Q1 Loss Narrower Than Expected, Sales Beat
news.google.com • -
Bristol Myers Squibb stock tumbles on cost-cutting initiative
news.google.com • -
Why Bristol Myers Squibb Stock Is Sinking Today
news.google.com • -
Why Bristol Myers Squibb Stock Is Sinking Today
news.google.com • -
Bristol-Myers Squibb Layoffs 2024: What to Know About the Latest BMY Job Cuts
investorplace.com • -
Bristol Myers Squibb (BMY) Q1 2024 Earnings Call Transcript
news.google.com • -
Is Bristol Myers Squibb Stock a Millionaire Maker?
news.google.com • -
Bristol-Myers stock drops amid plans to cut jobs (NYSE:BMY)
news.google.com • -
Merck jumps on profit beat as Bristol Myers Squibb slips to a loss
proactiveinvestors.com • -
Bristol Myers Squibb shares fall amid sluggish sales of some newer drugs
news.google.com • -
Bristol Myers: heavy quarterly loss on charges
news.google.com • -
Bristol-Myers stock falls despite Q1 beat (NYSE:BMY)
news.google.com • -
Bristol Myers: Q1 Earnings Snapshot
news.google.com • -
Bristol Myers posts quarterly loss, revenue rises 5%
reuters.com • -
Is Bristol Myers Squibb A Buy At These Bottom Levels?
seekingalpha.com • -
3 Undervalued Dividend Stocks to Buy Now to Beat the S&P 500
investorplace.com • -
3 Pharma Stocks That Are Money-Printing Machines in 2024
investorplace.com • -
6 Ultimate Dividend Stocks for Long-Term Passive Income Growth
247wallst.com • -
US biopharma first quarter earnings seen stable amid low expectations
proactiveinvestors.com • -
5 Relatively Secure And Cheap Dividend Stocks To Invest In - April 2024
seekingalpha.com • -
The 3 Most Undervalued Biotech Stocks to Buy in April 2024
investorplace.com • -
The Bargain Hunter's Dream: 3 Underpriced Stocks Poised for Massive Gains
investorplace.com • -
10 Dividend Growth Stocks: March 2024
seekingalpha.com • -
The 3 Best Biotech Stocks to Buy in Q2 2024
investorplace.com • -
Is Bristol Myers Squibb Stock a Buy?
fool.com • -
The Healthcare Bargain Blitz: 7 Undervalued Stocks to Inject into Your Portfolio
investorplace.com • -
2 More Potential Biotech Buyout Targets
seekingalpha.com • -
US FDA expands use of Bristol Myers' cancer therapy
reuters.com • -
Get Paid To Wait: 13 Potential Dividend Opportunities
seekingalpha.com • -
Bristol-Myers Squibb: Finally Trending Up
seekingalpha.com •